ALT5 Sigma Reports Strong Q4 and Full-Year 2024 Results, Achieves Milestones with Record Revenue, 1,000+ Customers, and Strategic Leadership Appointments

Stock Information for Applied Genetic Technologies Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Applied Genetic Technologies Corporation

ALT5 Sigma Corporation and Fundamental Interaction Usher in New Era of Institutional Crypto Trading Access for Finra Broker-Dealers
ALT5 Sigma Signals Readiness as U.S. Stablecoin Legislation Passes into Law
ALT5 Sigma Corporation Added to the Russell Microcap Growth Index, Russell 3000E Index and Russell 3000E Growth Index
ALT5 Sigma Corporation's Crypto-as-a-Service Platform Enables Stablecoin Management, Integration, and Utility Across All Leading Blockchains
ALT5 Sigma to Exhibit at iFX EXPO International June 17-19, 2025
ALT5 Sigma Launches Lightning Network Integration to Power Instant Bitcoin and Tether Payments in Partnership with Voltage
ALT5 Sigma Corporation Announces Record Date for Alyea Therapeutics Corporation Transaction
ALT5 Sigma Reports Record First Quarter 2025 and Announces Acquisition of Mswipe

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.